Epinephrine and norepinephrine can play an important role in basic developmental processes such as embryogenesis and morphogenesis, regulating cell proliferation, differentiation and migration. We showed that b-adrenergic receptors can mediate the effects of catecholamines on preimplantation embryos in our previous work. In the present study, we designed specific oligonucleotide primers which can distinguish among all members of the a-adrenergic receptor family, and showed (using RT-PCR) that the a2C-adrenergic receptor is transcribed in ovulated oocytes, 8-to 16-cell morulae and expanded blastocysts. We did not detect the a2C-adrenoceptor transcript in 4-cell embryos. Our immunohistochemical study showed the presence of a-2C-adrenoceptor protein in ovulated oocytes, 8-to 16-cell embryos and blastocysts, but the signal in 4-cell embryos was weak, and probably represents remaining protein of maternal origin. We did not detect any other a-adrenergic receptor in preimplantation embryos and oocytes. Exposure of mouse preimplantation embryos to the a2-adrenergic agonist UK 14 304 led to significant reduction of the embryo cell number, and the effect was dose dependent. Our results suggest that epinephrine and norepinephrine could affect the embryo development in the oviduct via adrenergic receptors directly and support the opinion that maternal stress can influence the embryo even in very early pregnancy.
Introduction
Epinephrine and norepinephrine are well-known neurotransmitters and hormones that play an essential role in the regulation of the cardiovascular system and energy metabolism, especially in the case of stress or increased energy need. In addition to these well-known effects, epinephrine and norepinephrine can also play an important role in basic developmental processes such as embryogenesis and morphogenesis, regulating cell proliferation, differentiation, and migration (for review, see Buznikov et al. 1996 , Pendleton et al. 1998 , Weiss et al. 1998 , Herlenius & Lagercrantz 2001 . The essential role of epinephrine and norepinephrine in mouse fetal development has been clearly demonstrated, when mice lacking the capability to synthesize these compounds died in utero or shortly after birth (Kobayashi et al. 1995 , Thomas et al. 1995 , Zhou et al. 1995 .
In our previous work, we demonstrated the possibility of direct influence of epinephrine and norepinephrine on the very early embryo (before its implantation into the uterus) via three subtypes of b-adrenergic receptors (Č ikoš et al. 2005) . The b-adrenoceptors belong, together with a1-and a2-adrenoceptors, to the adrenergic receptor family of G protein-coupled receptors. To transduce extracellular signals, the receptors couple to heterotrimeric GTP-binding (G) proteins which activate various effectors. The b-adrenoceptors couple predominantly to Gs proteins (G proteins which stimulate adenylyl cyclase activity), a1-adrenoceptors couple predominantly to Gq proteins (G proteins which stimulate phospholipase C activity) and a2-adrenoceptors couple predominantly to Gi proteins (G proteins which inhibit adenylyl cyclase activity). Signaling pathways leading from adrenergic receptors then regulate the activity of metabolic enzymes, ion channels or transcription factors (for review see, Watson & Arkinstall 1994 , Saunders & Limbird 1999 . Moreover, the adrenergic receptors can activate mitogen-activated protein kinases and thereby influence fundamental cellular processes (Alblas et al. 1993 , DeGraff et al. 1999 , Schramm & Limbird 1999 , Kim et al. 2002 , Shizukuda & Buttrick 2002 , Pullar & Isseroff 2003 .
To ascertain whether epinephrine and norepinephrine could influence the preimplantation embryo also via a-adrenergic receptors, in the present study we examined the expression of all subtypes of a1-and a2-adrenergic receptors in mouse embryos at various stages of preimplantation development.
Materials and Methods

Informatics analysis and primer design
Nucleotide sequences of mouse adrenergic receptors were obtained from public databases (GenBank, available at http://www.ncbi.nlm.nih.gov/ and GPCRDB: Information system for G protein-coupled receptors, available at http://www.gpcr.org/7tm/). MRNA nucleotide sequences of a1A-, a1B-, a1D-, a2A-, a2B-, and a2C-adrenergic receptors (GenBank accesion numbers: AF031431, XM _126326, S80044, M99377, M94583, M97516) were aligned using Clustal W (Higgins et al. 1996) and Blast 2 algorithms (Altschul et al. 1997) . The regions which do not exert significant nucleotide homology among the members of the a-adrenergic receptor family were selected for location of primers. The primers were designed using the program Primer 3 (available at http://biotools.umassmed.edu/ bioapps/primer3_www.cgi) and analysis of appropriate PCR products for recognition sites of restriction enzymes was performed using the program Webcutter 2.0 (available at http://rna.lundberg.gu.se/cutter2/).
Embryo recovery
All animal experiments were approved by the Ethical Committee of the Institute of Animal Physiology SAS, Košice. Female mice (ICR strain, Velaz, Prague, Czech Republic; 4-5 weeks old) underwent superovulation treatment by i.p. injection of 5 IU of serum gonadotropin (Folligon, Intervet International Bv. Boxmeer, Holland), followed 46 h later by administration of 5 IU of human chorionic gonadotropin (hCG, Organon, Oss, Holland). The mice were killed by cervical dislocation 24 h after hCG and unfertilized oocytes (at metaphase II) were isolated by flushing from the oviduct. To obtain preimplantation embryos, females were mated with males of the same strain overnight (mating was confirmed by identification of a vaginal plug), killed by cervical dislocation (57-, 72-, or 98 h after hCG) and the embryos (4-cell embryos, 8-16-cell morulae and expanded blastocysts) were isolated by flushing from the oviduct or uterus. Oocytes and embryos were washed in several drops of flushing-holding (FHM) medium (Lawits & Biggers 1993) containing 1% BSA and pooled according to their morphology. Cumulus cells were removed with 0.1% hyaluronidase (Sevac, Prague, Czech Republic).
RT-PCR
Total RNA was extracted from batches of 100-150 mouse preimplantation embryos and unfertilized oocytes. The RNA was also isolated from mouse tissues known to be rich in a-adrenergic receptors (brain, heart and liver), which served as positive controls. Life technologies) and 0.5 mg acetylated BSA. The reaction was terminated by heating at 95 8C for 5 min. To check for the presence of genomic DNA contamination in the RNA preparations, reverse transcriptase negative controls (no reverse transcriptase in the reaction) were carried out in parallel, using half from each RNA sample. The cDNA preparations were then cleaned by ethanol precipitation (Liss 2002 ) and the cDNA pellets were diluted in an appropriate amount of 10 mM Tris (pH 8.3) so that 1 ml of the cDNA corresponded to 2.5 embryo/oocyte equivalents.
PCR amplification was carried out in the presence of 0.5 mM of each oligonucleotide primer (see Table 1 ), 50 mM KCl, 10 mM Tris-HCl pH 8.3, 2 mM MgCl 2 , 0.2 mM dNTPs (dATP, dTTP, dCTP, dGTP), and 0.05 units/ml Taq DNA polymerase (Invitrogen Life Technologies). One microliter of cDNA was amplified in 25 ml PCR mix. For a1B-, 1D-, 2A-, and 2B-adrenoceptors, an initial denaturation step at 95 8C for 2 min was followed by 40 cycles at 94 8C for 30 s and 68 8C for 90 s. For a1A-, and 2C-adrenoceptors an initial denaturation step at 95 8C for 2 min was followed by 40 cycles at 94 8C for 30 s, 63 8C for 45 s, and 72 8C for 45 s. To check for the presence of cross contamination, the reaction with water instead of cDNA was performed concurrently (blank reaction). Detection of b-actin transcript using b-actin primers (5 0 -GTGGGCCGCTCTAGG-CACCAA-3 0 and 5 0 -CTCTTTGATGTCACGCACGATTTC-3 0 , give a 539 bp PCR product; Temeles et al. 1994) served as a control for RNA integrity and the RT-PCR process.
The PCR products were analyzed using electrophoresis on a 2% agarose gel stained with SYBR Green I (Sigma). A 100 bp DNA ladder and a 25 bp DNA ladder (Invitrogen Life technologies) were used as markers to determine the size of the PCR products. To confirm the amplification of the correct sequences, we digested the obtained PCR products with appropriate restriction enzymes -amplification reactions were ethanol precipitated, and DNA pellets were dissolved in TE buffer (10mM Tris, 1mM EDTA, pH 8.0) and digested with the restriction enzyme in the appropriate reaction buffer.
Immunostaining
Preimplantation embryos and oocytes were isolated as described above and the zona pellucida was removed with 0.5% pronase in KSOM at 37 8C. Zona-free oocytes and embryos were washed thrice in PBS/BSA (PBS containing BSA; Sigma-Aldrich), fixed in methanol at 10 8C (Sigma-Aldrich) for 5 min, then washed in PBS/BSA, followed by washing in PBS/BSA/SAP (PBS/BSA containing 0.05% saponin (SAP); Sigma-Aldrich). Nonspecific immunoreactions were blocked with 2.25% normal donkey serum (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 0.1% saponin in PBS for 45 min at room temperature. The oocytes and embryos were incubated with the primary antibody raised against the a2C-adrenergic receptor (affinity-purified goat polyclonal antibody, a2C-AR C-20, Santa Cruz Biotechnology, 2 mg/ml) in PBS/BSA/SAP at 4 8C overnight. After extensive washing in PBS/BSA/SAP, specific secondary antibody coupled with fluorescein (donkey anti-goat IgG-FITC, Santa Cruz Biotechnology, 2 mg/ml) was used to visualize primary antibody reactions (30 min at room temperature). Afterwards, oocytes and embryos were washed in PBS/BSA/SAP and PBS/BSA, mounted on glass slides in UltraCruz mounting medium (Santa Cruz Biotechnology, contains DAPI for cell nuclei staining), sealed with coverslips and observed using an epifluorescent microscope (BX 51 Olympus, Tokyo, Japan).
Negative control groups of oocytes and embryos were incubated without the primary antibody or without the primary and secondary antibody, or with the primary antibody preadsorbed with an excess (20 times by weight) of the immunizing peptide according to the manufacturer's protocol (Blocking peptide, a2C-AR C-20 P, Santa Cruz Biotechnology). Oocytes and embryos in each experimental group (incubation with primary antibody) were evaluated by comparison with control groups of oocytes and embryos.
Embryo culture and morphological evaluation
The four-cell embryos were isolated by flushing from the oviduct in FHM medium 57 h after hCG. They were washed thrice in KSOM culture medium, transferred into 30 ml drops of KSOM media supplemented with UK 14 304 (Sigma-Aldrich) dissolved in DMSO or with the equivalent volume of DMSO alone and cultured in a humidified atmosphere with 5.0% CO 2 at 37 8C for 60 h. Three doses of UK 14 304 were used: UK 14 304 was dissolved in DMSO and added to a KSOM culture medium (Lawits & Biggers 1993) at final concentrations of 0.1, 1, and 10 mM at the beginning of the incubation period and then 20 and 40 h later. The control groups of embryos were cultured in the presence of the equivalent amounts of solvent (DMSO) added into the KSOM at the same time as UK 14 304 (the compounds were added in the volume of 1 ml).
After the 60 h of incubation, the embryos were stained with Hoechst 33 342 (20 mg/ml; Sigma-Aldrich) for 10 min at 37 8C, washed, sealed with coverslips, and observed using an epifluorescent microscope (BX 51 Olympus). The number of cell nuclei was determined in all embryos. Each embryo was assigned to one of the four classes according to the cell number (developmental stage). Following classes were established: embryos with cell number less than 16, embryos with cell number between 17 and 32, embryos with cell number between 33 and 64, and embryos with cell number 65 and more. The distribution of embryos among the four developmental classes was then analyzed.
To eliminate experimental bias, at least three independent series were performed in each experimental group (the three UK 14 304 doses and the control group) and the results were pooled. The following total numbers of embryos (n) were examined: 10 mM UK 14 304 nZ139; 1 mM UK 14 304 nZ113; 0.1 mM UK 14 304 nZ140; DMSO controls nZ148.
The One-way ANOVA followed by Duncan's test was used for evaluating the embryo cell number, while the chisquared test was used for analyzing embryo distribution. Differences of P%0.05 were considered significant.
Results
Primer design
We located the primers for a-adrenergic receptors mainly in regions encoding a portion of the receptor outside of transmembrane domains, which are less conserved than transmembrane domains. The primers for a1D-adrenoceptor also detect an alternative splice variant coding longer adrenoceptor isoform (GenBank accession number XM_141369). The primers for a1A-adrenoceptor do not detect two potential alternative Table 1 . Amplification reaction for each primer pair was optimalized using positive controls -mouse tissues known to be rich in the receptor (Fig. 1a) . The identity of each PCR product was verified by digestion with appropriate restriction enzymes according to the sequence information: digestion of the a1A-adrenoceptor PCR product (185 bp) with Alu I gave 112 and 73 bp DNA fragments, digestion of the a1B-adrenoceptor PCR product (140 bp) with Alu I gave 102 and 34 bp DNA fragments (the remaining 4 bp DNA fragment is not detectable on 2% agarose gel), digestion of the a1D-adrenoceptor PCR product (127 bp) with Hpa II gave 87 and 40 bp DNA fragments, digestion of the a2A-adrenoceptor PCR product (112 bp) with Hpa II gave 73 and 39 bp DNA fragments, digestion of the a2B-adrenoceptor PCR product (112 bp) with Taq I gave 74 and 38 bp DNA fragments, digestion of the a2C-adrenoceptor PCR product (105 bp) with Alu I gave 81 and 24 bp DNA fragments, and digestion with Mbo II gave 67 and 38 bp DNA fragments (Fig. 2) .
Expression of a-adrenergic receptor mRNAs
Mouse oocytes and preimplantation embryos at various developmental stages (four-cell embryos, 8-to 16-cell morulae and expanded blastocysts) were examined by RT-PCR using reaction conditions which were optimalized for each primer pair in the positive control tissues before examination. An amount of cDNA corresponding to 2.5 embryo/oocyte equivalents was amplified in 40 cycles and analyzed on agarose gel.
We detected a PCR product corresponding to the a2C-adrenergic receptor (105 bp) in oocytes, 8-to 16-cell morulae, and expanded blastocysts. No PCR product was detected in four-cell embryos or in the reactions where reverse transcriptase or cDNA were omitted (Fig. 1b) . Digestion of the 105 bp PCR product with appropriate restriction enzymes produced DNA fragments of the expected sizes: digestion with Alu I gave 81 and 24 bp DNA fragments and digestion with Mbo II gave 67 and 38 bp DNA fragments (Fig. 2) .
PCR products corresponding to other a-adrenergic receptor mRNAs were not detected in the oocytes and embryos, even after an increase of cDNA amount in PCR or after an additional 25 cycles of reamplification (data not shown).
The embryos produced a PCR fragment corresponding to the b-actin mRNA at all developmental stages, thus confirming the integrity of the RNA and the RT-PCR process (data not shown).
Immunohistochemical study
The immunoreactive a2C-adrenergic receptor was identified in oocytes, 8-to 16-cell morulae, and blastocysts, but the signal was weak in four-cell embryos (Fig. 3) . The specificity of the signal was confirmed using several controls: the immunostaining intensity was significantly reduced in controls incubated with the primary antibody preadsorbed with the immunizing peptide (Fig. 3 ) or in controls incubated without the B, digestion of the a1A-adrenoceptor PCR product with Alu I (112C 73 bp DNA fragments); C, digestion of the a1B-adrenoceptor PCR product with Alu I (102C34 bp DNA fragments); D, digestion of the a1D-adrenoceptor PCR product with Hpa II (87C40 bp DNA fragments); F, digestion of the a2C-adrenoceptor PCR product with Alu I (81C24 bp DNA fragments); G, digestion of the a2C-adrenoceptor PCR product with Mbo II (67C38 bp DNA fragments); H, digestion of the a2A-adrenoceptor PCR product with Hpa II (73C39 bp DNA fragments); I, digestion of the a2B-adrenoceptor PCR product with Taq I (74C38 bp DNA fragments). Lanes A, E, and J, molecular weight markers (MWM). The sizes of the MWM in base pairs (bp) are indicated to the left and the right of the panel respectively. primary antibody or without the primary and secondary antibody (data not shown). Table 2 shows the analysis of embryo distribution after incubation of the mouse preimplantation embryos with different doses of the a2-adrenoceptor agonist UK 14 304. Highly significant changes (P!0.001) in embryo distribution with an increased proportion of embryos with lower cell numbers and decreased proportion of embryos with higher cell numbers were found after the UK 14 304 treatment. Incubation of the embryos with UK 14 304 led to significant reduction of the mean embryo cell number in comparison with the control embryos and the response was dose dependent (Fig. 4) .
Effect of UK 14 304 on embryo development
Discussion
We showed that b-adrenergic receptors are expressed in mouse oocytes and preimplantation embryos in our previous work (Č ikoš et al. 2005) . To extend our knowledge to all members of the adrenergic receptor family, we proceeded to examine the expression of a-adrenergic receptors in mouse preimplantation embryos and oocytes. We detected the a2C-adrenoceptor transcript in oocytes, 8-to 16-cell embryos, and blastocysts, but not in four-cell embryos. These results suggest that ovulated oocytes express the a2C-adrenoceptor and that transcription of the embryonal a2C-adrenoceptor gene begins around the 8-to 16-cell stage. In accordance with the results of the RT-PCR experiment, our immunohistochemical study showed the presence of a2C-adrenoceptor protein in ovulated oocytes, 8-to 16-cell embryos, and blastocysts, but the signal in four-cell embryos was weak and probably represents the remaining protein of maternal origin. We did not detect any other a-adrenergic receptor in preimplantation embryos and oocytes. Taken together, the results of our previous work (Č ikoš et al. 2005) and the results of the present study indicate that two types of adrenergic receptors are expressed in mouse ovulated oocytes and preimplantation embryos. The receptors are under the control of the same natural ligands (epinephrine, norepinephrine) but they couple primarily to G proteins with opposing actions on adenylyl cyclase activity (b-adrenoceptors to Gs, a2-adrenoceptors to Gi). Co-stimulation of the two receptors in the same cell might be expected to antagonize each other's signaling. However, the ability of a Gi protein-coupled receptor to decrease cAMP production in the cell is not automatic; it depends, for example, on the isoform of adenylyl cyclase present in the cell (for review, see Cooper 2003) . Moreover, it has been shown that under certain circumstances a2-adrenoceptors can even stimulate cAMP production in some cell types, and the effect of a2-adrenoceptors on cAMP production appears to be dependent on agonist concentration (Duzic & Lanier 1992 , Pepperl & Regan 1993 , Eason & Liggett 1995 , Pohjanoksa et al. 1997 ). An interesting cross-talk between a2-adrenoceptors and b2-adrenergic receptor has been shown in pregnant rat myometrium with different receptor interactions at midpregnancy and in late pregnancy. By themselves, a2-adrenoceptor agonists did not significantly influence adenylyl cyclase activity in myometrial cells, but they were able to modulate the enzyme activity after b2-adrenoceptor stimulation (Mhaouty et al. 1995 , LimonBoulez et al. 2001 . The possibility of cross-talk between a2-and b-adrenoceptors has also been shown in brain cells (Atkinson & Minneman 1992 , Shivachar & Eikenburg 1999 . These results indicate that simultaneous activation of b-and a2-adrenergic receptors in the same cell need not necessarily have a contradictory effect on cAMP production; the signaling pathway employed by the receptor depends on the cell type and physiological status as well as on the intensity of receptor stimulation by a particular agonist.
To examine the effect of a2C-adrenoceptor activation on the development of mouse preimplantation embryos, we exposed the embryos to three doses of the a2-adrenergic agonist UK 14 304. We found that the percentage of embryos which reached higher developmental stages was significantly reduced after the exposure of the embryos to UK 14 304. Estimation of the mean embryo cell number revealed that the effect of UK 14 304 was dose dependent and led to significantly lower numbers of cells in UK 14 304-treated embryos in comparison with control embryos. These results indicate that activation of a2C-adrenoceptor in mouse preimplantation embryos can inhibit cell proliferation, similarly as shown for b-adrenergic receptors (Č ikoš et al. 2005) . The influence of adrenergic receptors on fundamental cellular processes has been demonstrated in various mammalian cell types, particularly regulation of cell proliferation, migration, and apoptosis by activated b-and a2-adrenoceptors (Kennedy et al. 1983 , Seuwen et al. 1990 , Wang & Limbird 1997 , Slotkin et al. 2000 , Cussac et al. 2002 , Kim et al. 2002 , Shizukuda & Buttrick 2002 , Pullar & Isseroff 2003 , Zhu et al. 2003 . Cell responses to stimulation of adrenergic receptors are mediated via various signaling pathways. The b-adrenoceptors coupled predominantly to Gs proteins regulate the activity of metabolic enzymes, ion channels, or transcription factors. The a2-adrenoceptors coupled primarily to Gi proteins inhibit the Statistical difference between the group of embryos treated with 10 mM UK 14 304 and the embryos treated with the two lower doses of UK 14 304: *P!0.05, **P!0.01. activity of adenylyl cyclase and voltage-gated Ca 2C channels and activate receptor-operated K C channels (for review see, Watson & Arkinstall 1994 , Saunders & Limbird 1999 ). Moreover, stimulation or inhibition of mitogen-activated protein kinases by activated adrenergic receptors has been shown in several cell types utilizing a variety of signaling pathways (Alblas et al. 1993 , DeGraff et al. 1999 , Schramm & Limbird 1999 , Lindquist et al. 2000 , Hutchinson et al. 2002 , Shizukuda & Buttrick 2002 , Pullar & Isseroff 2003 .
Natural ligands for adrenergic receptors, epinephrine and norepinephrine, have been detected in the oviductal fluid of some species. Concentrations of these catecholamines varied with the region of the oviduct and with the stage of the estrous cycle (Khatchadourian et al. 1987 , Way et al. 2001 . The possible sources of norepinephrine and epinephrine in the oviductal fluid could be nerves, blood circulation or graafian follicles (Helm et al. 1982 , Fernandez-Pardal et al. 1986 , Kannisto et al. 1986 , Itoh et al. 2000 , Kotwica et al. 2003 . Moreover, it was speculated that catecholamines could be produced also by the early embryo itself (Burden & Lawrence 1973 , Sadykova et al. 1990 ). Epinephrine and norepinephrine present in oviductal fluid could influence the oviduct epithelium via adrenergic receptors which have been shown in oviduct epithelial cells of several species (Tolszczuk & Pelletier 1988 , Dickens et al. 1993 , Einspanier et al. 1999 . Increased fluid formation, effects on Cl K ion transport and electrical potential differences have been shown after treatment of rabbit oviductal cells with agonists of adrenergic receptors (Dickens et al. 1993 , Dickens & Leese 1994 . Besides, the effects on the oviduct epithelium, adrenoceptor agonists can also influence the functioning of spermatozoa in the oviduct, including capacitation and acrosome reaction (Way & Killian 2002 , Adeoya-Osiguwa et al. 2006 .
It is well known that circulating levels of epinephrine and norepinephrine are highly elevated during stress and trauma. Animal experiments have convincingly demonstrated that prenatal maternal stress can significantly affect the pregnancy outcome (for review see Mulder et al. 2002) . Some results suggest that maternal stress can negatively impact on the embryo even at very early stages of its development. For instance, it has been shown that litter sizes of female hamsters stressed during early pregnancy were significantly smaller than those of controls, with fetal loss occurring between days 5 and 10 of pregnancy (Pratt & Lisk 1989) . In humans, it has been demonstrated that pregnancies characterized by increased maternal cortizol (commonly used stress marker) during the first three weeks after conception are more likely to result in spontaneous abortion. (Nepomnaschy et al. 2006) .
Our results indicate that, besides b-adrenergic receptors, the a2C-adrenoceptor is also expressed in mouse oocytes and preimplantation embryos. We also found that ligands for the receptors are capable of affecting the preimplantation embryo development in vitro. These results suggest that epinephrine and norepinephrine could directly affect embryo development in the oviduct via adrenergic receptors and support the opinion that maternal stress can influence the embryo even in very early pregnancy.
